XML 66 R44.htm IDEA: XBRL DOCUMENT v3.24.1.u1
SEGMENT REPORTING (Tables)
12 Months Ended
Dec. 31, 2023
Segment Reporting [Abstract]  
Reconciliation of Financial Measures of Segments to Consolidated Totals
The following is a reconciliation of financial measures of the Company’s segments to the consolidated totals:
Year ended December 31, 2023
Period from July 28 to December 31, 2022
SuccessorSuccessor
(In thousands)Obagi SkincareMilk MakeupTotalObagi SkincareMilk MakeupTotal
Net revenue$117,651 $100,487 $218,138 $61,090 $31,283 $92,373 
Cost of goods sold41,069 35,492 76,561 44,973 15,684 60,657 
Gross profit$76,582 $64,995 $141,577 $16,117 $15,599 $31,716 
Reconciliation of Segment Gross Profit to Net Income (Loss) Before Income Taxes
The following table reconciles segment gross profit to net income (loss) before income taxes for the year ended December 31, 2023 (Successor Period):
Year ended December 31, 2023Period from
July 28 to December 31,
2022
(In thousands)Successor
Gross profit$141,577 $31,716 
Selling, general and administrative220,313 88,926 
Research and development3,195 1,796 
Loss on impairment of goodwill— 68,715 
Interest expense, net18,906 6,230 
Change in fair value of derivative warrant liabilities 10,337 (6,793)
Other expenses (income), net1,769 (798)
Loss before income taxes$(112,943)$(126,360)
Income tax (benefit) expense(6,975)(5,803)
Net loss$(105,968)$(120,557)